Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Colorectal cancer | R-HSA-4791275 | map05210 | quipazine | 4477 | drug-path |
Ribosome | R-HSA-5368277 | map03010 | quipazine | 4477 | drug-path |
Glioma | Q9NZM4 | map05214 | PHA-00665752 | None | drug-path |
Renal cell carcinoma | R-HSA-9794523 | map05211 | PHA-00665752 | None | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | PHA-00665752 | None | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | PHA-00665752 | None | drug-path |
Pancreatic cancer | R-HSA-9700206 | map05212 | PHA-00665752 | None | drug-path |
Cell cycle | R-HSA-1640170 | map04110 | PHA-00665752 | None | drug-path |
Prostate cancer | R-HSA-2990872 | map05215 | PHA-00665752 | None | drug-path |
Bladder cancer | R-HSA-9700206 | map05219 | PHA-00665752 | None | drug-path |
p53 signaling pathway | R-HSA-168638 | map04115 | PHA-00665752 | None | drug-path |
Non-homologous end-joining | R-HSA-5693571 | map03450 | PHA-00665752 | None | drug-path |
Mismatch repair | R-HSA-5358508 | map03430 | PHA-00665752 | None | drug-path |
Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | PHA-00665752 | None | drug-path |
GnRH signaling pathway | R-HSA-168638 | map04912 | PHA-00665752 | None | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | AG-028671 | None | drug-path |
Pathways in cancer | R-HSA-9824443 | map05200 | AG-028671 | None | drug-path |
Shigellosis | 0 | map05131 | AG-028671 | None | drug-path |
Pathogenic Escherichia coli infection | R-HSA-9609646 | map05130 | AG-028671 | None | drug-path |
Cell cycle | R-HSA-1640170 | map04110 | AG-028671 | None | drug-path |